Obsesif-Kompulsif Hastalıklar - Tanı ve Tedavileri

Abramowitz JS, Wheaton MG, Storch EA (September 2008). “The status of hoarding as a symptom of obsessive-compulsive disorder”. Behaviour Research and Therapy. 46 (9): 1026–1033. Doi:10.1016/j.brat.2008.05.006.

American Psychiatric Association Work Group on Obsessive-Compulsive Disorder. Practice guideline for the treatment of patients with obsessive-compulsive disorder. Am J Psychiatry. July 2007. 164(suppl):1-56.

American Psychiatric Association. 2013. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Washington, DC: American Psychiatric Association; Arlington, VA.

Andrade C. Ondansetron augmentation of serotonin reuptake inhibitors as a treatment strategy in obsessive-compulsive disorder. J Clin Psychiatry. 2015 Jan. 76 (1):e72-5

Ardouin C et al. (2006) Pathological gambling in Parkinson's disease improves on chronic subthalamic nucleus stimulation. Mov Disord 21: 1941-1946

Arnold PD, Rosenberg DR, Mundo E, Tharmalingam S, Kennedy JL, Richter MA. Association of a glutamate (NMDA) subunit receptor gene (GRIN2B) with obessive-compulsive disorder: a preliminary study. Psychopharmacology. August 2004. 174:530-538.

Arnold PD, Sicard T, Burroughs E, Richter MA, Kennedy JL. Glutamate transporter gene SLC1A1 associated with obsessive-compulsive disorder. Arch Gen Psychiatry. 2006 Jul. 63(7):769- 76.

Avanzi M et al. (2006) Prevalence of pathological gambling in patients with Parkinson's disease. Mov Disord 21: 2068-2072

Ayers CR, Saxena S, Golshan S, Wetherell JL (February 2010). “Age at onset and clinical features of late life compulsive hoarding”. International Journal of Geriatric Psychiatry. 25 (2): 142–149. Doi:10.1002/gps.2310.

Dell'Osso; A. C. Altamura; E. Mundo; D. Marazziti; E. Hollander (2007), Diagnosis and Treatment of Obsessive-compulsive Disorder and Related Disorders Int J Clin Pract. 61(1):98-104.

Baarendse PJ, Counatte DS. Early social experience is critical fort he development of cognitive control and dopamine modulation of prefrontal cortex function. Neuropsychopharmacology. 2013; 38(8):1485-1494.

Balodis IM, Kober H, Worhunsky PD, et al. Diminished frontostriatal activity during processing of monetary rewards and losses in pathological gambling. Biol Psychiatry. 2012; 71:749-757.

Barbano MF, Cador M. Opioids for hedonic experience and dopamine to get ready for it. Psychopharmacology. 2007; 191:497-506.

Barlow JH, Ellard DR, Hainsworth JM, Jones FR, Fisher A. A review of self-management interventions for panic disorders, phobias and obsessive-compulsive disorders. Acta Psychiatr Scand. 2005 Apr. 111(4):272-85.

Bartley CA, Bloch MH. Meta-analysis: pharmacological treatment of pathological gambling. Exp Rev Neurother. 2013; 13:887-894.

Bartz, J.A. and Hollander, E. (2006) Is Obsessive-Compulsive Disorder an Anxiety Disorder? Progress in Neuro-Psychopharmacology and Biological Psychiatry, 30, 338-352.

Baylé FJ, Caci H, Millet B, Richa S, Olié JP. Psychopathology and comorbidity of psychiatric disorders in patients with kleptomania.Am J Psychiatry.2003,160(8):1509–13.

Berlin HA, Braun A, Simeon D, et al. A double-blind, placebo-controlled trial of topiramate for pathological gambling. World J Biol Psychiatry. 2013; 14:121-128.

Bienvenu OJ et al. (2000) The relationship of obsessive-compulsive disorder to possible spectrum disorders: results from a family study. Biol Psychiatry 48: 287-293

Bienvenu OJ, Samuels JF, Wuyek LA, Liang KY, Wang Y, Grados MA, et al. Is obsessive-compulsive disorder an anxiety disorder, and what, if any, are spectrum conditions? A family study perspective. Psychol Med. 2012 Jan. 42(1):1-13.

Blanco C, Grant J, Petry NM, Simpson HB, Alegria A, Liu SM, Hasin D. Prevalence and correlates of shoplifting in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Am J Psychiatry. 2008 Jul; 165(7):905–13.

Blaszczynski A. Pathological gambling and obsessive-compulsive spectrum disorders. Psychological reports. 1999; 84:107-113.

Bloch MH, Landeros-Weisenberger A, Kelmendi B, Coric V, Bracken MB, Leckman JF. A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder. Mol Psychiatry. 2006 Jul. 11(7):622-32.

Bonci A and Singh V (2006) Dopamine dysregulation syndrome in Parkinson's disease patients: from reward to penalty. Ann Neurol 59: 733-734

Borue X, Sharma M, Hudak R. Biological treatments for obsessive-compulsive and related disorders. J Obsessive Compuls Relat Disord. 2015;6:7–26.

Brewer JA and Potenza MN (2007) The neurobiology and genetics of impulse control disorders: relationships to drug addictions. Biochem Pharmacol. doi:doi: 10.1016/j.bcp.2007.06.043

Brewer JA, Potenza MN. The neurobiology and genetics of impulse control disorders: relationships to drug addictions. Biochem Pharmacol. 2008; 75:63-75.

Bulut S D, Özdel K, Kısa C, Belirtiden Bozukluğa İstifleme. Hoarding, Psikiyatride Güncel Yaklaşımlar- Current Approaches in Psychiatry 2015;7(3):319-332 doi:10.5455/cap. 20141220023913

Burn DJ and Troster AI (2004) Neuropsychiatric complications of medical and surgical therapies for Parkinson's disease. J Geriatr Psychiatry Neurol 17: 172-180

Çakmak S, Lut Tamam L, Review, Gambling Disorder: Journal of Dependence, 2018; 19(3):78-97

Campbell-Meiklejohn DK, Woolrich MW, Passingham RE, et al. Knowing when to stop: the brain mechanisms of chasing losses. Biol Psychiatry. 2008; 63:293-300.

Carlbring P, Jonsson J, Josephson H, et al. Motivational interviewing versus cognitive behavioral group therapy in the treatment of problem and pathological gambling: a randomized controlled trial. Cogn Behav Ther. 2010; 39:92-103.

Chambers RA and Potenza MN (2003) Neurodevelopment, impulsivity and adolescent gambling. J Gambl Stud 19: 53-84

Choi J-S, Shin Y-C, Jung WH, et al. Altered brain activity during reward anticipation in pathological gambling and obsessive-compulsive disorder. PLoS One. 2012; 7:e45938.

Cocker PJ, Le Foll B, Rogers RD, Winstanley CA. A selective role for dopamine D4 receptors in modulating reward expectancy in a rodent slot machine task. Biol Psychiatry. 2014; 75:817-824.

Coric V, Taskiran S, Pittenger C, Wasylink S, Mathalon DH, Valentine G, et al. Riluzole augmentation in treatment-resistant obsessive-compulsive disorder: an open-label trial. Biol Psychiatry. 2005 Sep1.58(5):424-8.238

Cromer KR, Schmidt NB, Murphy DL (November 2007). “Do traumatic events influence the clinical expression of compulsive hoarding?”. Behaviour Research and Therapy. 45 (11): 2581– 2592. Doi:10.1016/j.brat.2007.06.005.

Crone C, Norberg MM (August 2018). “Scared and surrounded by clutter: The influence of emotional reactivity”. Journal of Affective Disorders. 235: 285–292.

Dannon PN, Shoenfeld N. Pathological gambling: an impulse control disorder? Measurement of impulsivity using neurocognitive tests. Isr Med Assoc J 2010; 12(4):238-248.

Desai RA (2004) Older adults. In Pathological Gambling: A Clinical Guide to Treatment, 83–96 (Eds Grant JE and Potenza MN) Washington, DC: American Psychiatric Publishing

Diskin KM, Hodgins DC. A randomized controlled trial of a single session motivational intervention for concerned gamblers. Behav Res Ther. 2009; 47:382-388.

Dodd ML et al. (2005) Pathological gambling caused by drugs used to treat Parkinson disease. Arch Neurol 62: 1377-1381

Dold M, Aigner M, Lanzenberger R, Kasper S. Antipsychotic augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a meta-analysis of double-blind, randomized, placebo-controlled trials. Int J Neuro-psychopharmacol. 2013;16(3):557– 74.

Driver-Dunkley E et al. (2003) Pathological gambling associated with dopamine agonist therapy in Parkinson's disease. Neurology 61: 422-423

Eryılmaz G, Erkmen H, Gül I G., Transcranial Direct Current Stimulation. Anatolian Journal of Psychiatry. 2015; 16:138-142.

Evans AH et al. (2005) Factors influencing susceptibility to compulsive dopaminergic drug use in Parkinson disease. Neurology 65: 1570-1574

Evans AH et al. (2006) Relationship between impulsive sensation seeking traits, smoking, alcohol and caffeine intake, and Parkinson's disease. J Neurol Neurosurg Psychiatry 77: 317-321

Ferrão AY, Diniz JB, Lopes AC, Shavitt RG, Greenberg B, Miguel E, Resistance and refractoriness in obsessive-compulsive disorder, Braz. J. Psychiatry 29 (suppl 2), Oct 2007 https://Doi. org/10.1590/S1516-44462006005000059

Foa EB, Wilson R. Stop Obsessing: How to Overcome Your Obsessions and Compulsions. Revis ed. New York: Bantam Dell; 2001

Fontenelle LF, Muhlbauer JE, Albertella L, Eppingstall J (2021-01-01). “Traumatic and stressful life events in hoarding: the role of loss and deprivation”. European Journal of Psychotraumatology. 12 (1): 1947002. Doi:10.1080/20008198.2021.1947002.

Frost RO, Steketee G, Tolin DF (October 2011). “Comorbidity in hoarding disorder”. Depression and Anxiety. 28 (10): 876–884.

Gallagher DA et al. (2007) Pathological gambling in Parkinson's disease: risk factors and differences from dopamine dysregulation: an analysis of published case series. Mov Disord 22: 1757-1763

Galpern WR and Stacy M (2007) Management of impulse control disorders in Parkinson's disease. Curr Treat Options Neurol 9: 189-197

Ghaleiha A, Entezari N, Modabbernia A, Najand B, Askari N, Tabrizi M, et al. Memantine add-on in moderate to severe obsessive-compulsive disorder: randomized double-blind placebo-controlled study. J Psychiatr Res. 2013 Feb. 47(2):175-80.

Goudriaan AE, De Ruiter MB, Van Den Brink W, et al. Brain activation patterns associated with cue reactivity and craving in abstinent problem gamblers, heavy smokers and healthy controls: an fMRI study. Addiction Biol. 2010; 15:491-503.

Grant J, Chamberlain SR. Impulsive action and impulsive choice across substance and behavioral addictions: Cause or consequence? Addict Behav 2014; 39:1632-1639.

Grant JE and Potenza MN (2006) Compulsive aspects of impulse control disorders. Psychiatr Clin North Am 29: 539-551

Grant JE and Potenza MN (2006) Escitalopram treatment of pathological gambling with co-occurring anxiety: an open-label pilot study with double-blind discontinuation. Int Clin Psychopharmacol 21: 203-209

Grant JE and Potenza MN (2006) Impulse control disorders. In A Clinical Text of Men's Mental Health, 205-232 (Eds Grant JE and Potenza MN) Washington, DC: American Psychiatric Publishing

Grant JE et al. (2003) Paroxetine treatment of pathological gambling: a multi-center randomized controlled trial. Int Clin Psychopharmacol 18: 243-249

Grant JE et al. (2005) Impulse control disorders in adult psychiatric inpatients. Am J Psychiatry 162: 2184-2188

Grant JE, R Samuel. Chamberlain, Symptom Severity and Its Clinical Correlates in Kleptomania, Ann Clin Psychiatry. 2018 May ; 30(2): 97–101

Grant JE, Correia S, Brennan-Krohn T. White matter integrity in kleptomania: a pilot study. Psychiatry Res. 2006 Oct 30; 147(2–3):233–7.

Grant JE, Kim SW, Hartman BK. A double-blind, placebo-controlled study of the opiate antagonist naltrexone in the treatment of pathological gambling urges. J Clin Psychiatry. 2008; 69:783-789.

Grant JE, Kim SW, McCabe JS. A Structured Clinical Interview for Kleptomania (SCI-K): preliminary validity and reliability testing. Int J Methods Psychiatr Res. 2006; 15:83–94.

Grant JE, Kim SW, Odlaug BL. A double-blind, placebo-controlled study of the opiate antagonist, naltrexone, in the treatment of kleptomania. Biol Psychiatry. 2009; 65(7):600–606.

Grant JE, Kim SW, Odlaug BL. N-acetyl cysteine, a glutamate-modulating agent, in the treatment of pathological gambling: a pilot study. Biol Psychiatry. 2007; 62:652-657.

Grant JE, Leppink EW, Redden SA, et al. COMT genotype, gambling activity, and cognition. J Psychiatr Res. 2015; 68:371-376.

Grant JE, Odlaug BL, Chamberlain SR, et al. A randomized, placebo-controlled trial of N-acetylcysteine plus imaginal desensitization for nicotine-dependent pathological gamblers. J Clin Psychiatry. 2014 ;75:39-45.

Grant JE, Odlaug BL, Kim SW. Kleptomania: clinical characteristics and relationship to substance use disorders. Am J Drug Alcohol Abuse. 2010 Sep; 36(5):291–5.

Grant JE, Odlaug BL, Potenza MN, Hollander E, Kim SW. Nalmefene in the treatment of pathological gambling: multicentre, double-blind, placebo-controlled study. Br J Psychiatry. 2010; 197:330-331.

Grant JE, Odlaug BL. National Center for Responsible Gaming. What clinicians need to know about gambling disorders. Vol. 7. Washington, DC: NCRG; 2012. Psychosocial interventions for gambling disorders; pp. 38–52. Increasing the odds: a series dedicated to understanding gambling disorders. At http://www.ncrg.org/resources/monographs.

Grant JE, Potenza MN, Krishnan-Sarin S, Cavallo DA, Desai RA. Stealing among high school students: prevalence and clinical correlates. J Am Acad Psychiatry Law. 2011; 39(1):44–52.

Grayson J. Freedom From Obsessive Compulsive Disorder: A Personalized Recovery Program for Living With Uncertainty. New York: Berkley Publishing Group; 2004.

Greenberg WM, Benedict MM, Doerfer J, Perrin M, Panek L, Cleveland WL, et al. Adjunctive glycine in the treatment of obsessive-compulsive disorder in adults. J Psychiatr Res. 2009 Mar. 43(6):664-70.

Grisham JR, Frost RO, Steketee G, Kim HJ, Hood S (2006). “Age of onset of compulsive hoarding”.Journal of Anxiety Disorders. 20 (5): 675–86. Doi:10.1016/j.janxdis. 2005.07.004.

Grisham JR, Norberg MM (2010-06-30). “Compulsive hoarding: current controversies and new directions”. Dialogues in Clinical Neuroscience. 12 (2): 233–240. Doi:10.31887/ DCNS.2010.12.2/jgrisham.

Grosset KA et al. (2006) Problem gambling on dopamine agonists: not such a rarity. Mov Disord 21: 2206-2208

Gul V, (2024) Anksiyete ve Travmatik Stres Bozuklukları, Akademisyen Kitabevi Yayınları, ISBN 978-625-399-950-6

Haghighi M, Jahangard L, Mohammad-Beigi H, Bajoghli H, Hafezian H, Rahimi A, et al. In a double-blind, randomized and placebo-controlled trial, adjuvant memantine improved symptoms in inpatients suffering from refractory obsessive-compulsive disorders (OCD). Psychopharmacology (Berl). 2013 Mar 23.

Hollander E, Pallanti S, Allen A, et al. Does sustained-release lithium reduce impulsive gambling and affective instability versus placebo in pathological gamblers with bipolar spectrum disorders? Am J Psychiatry. 2005; 162:137-145.

Hollander E, Pallanti, S, Allen A, Sood E, Rossi NB (2005) Does sustained-release lithium reduce impulsive gambling and affective instability versus placebo in pathological gamblers with bipolar spectrum disorders? Am J Psychiatry 162: 137-145

Hollander E, Wong CM. Obsessive-compulsive spectrum disorders. J Clin Psychiatry. 1995; 56 (suppl 4):3-6.

Internationale Klassifikation psychischer Störungen : ICD-10, Kapitel V ( F, klinisch-diagnostische Leitlinien / hrsg. von H. Dilling, W. Mombour und M. H. Schmid, Verlag Hans Huber, 3.Auflage

Karim R, Chaudhri P. Behavioral addictions: an overview. J Psychoactive Drugs. 2012;44:5-17.

Kim SW, Grant JE, Adson DE, et al. A double-blind placebo-controlled study of the efficacy and safety of paroxetine in the treatment of pathological gambling. J Clin Psychiatry. 2002; 63:501-507.

Klos K J, Bower, J H, Josephs,K A, Matsumoto, JY, Ahlskog J E. Pathological hypersexuality predominantly linked to adjuvant dopamine agonist therapy in Parkinson's disease and multiple system atrophy. 2005 Sep; Parkinsonism Relat Disord 11(6):381-6. 11: 38 1-386

Komossa K, Depping AM, Meyer M, Kissling W, Leucht S. Second-generation antipsychotics for obsessive compulsive disorder. Cochrane Database Syst Rev. 2010 Dec 8. 12:CD008141.

Koob GF, Volkow ND. Neurocircuitry of addiction. Neuropsychopharmacology. 2010; 5:217-238.

Koran LM, Aboujaoude E. Promising treatments for obsessive-compulsive disorder: a call for additional research. Curr Med Chem. 2018;25(41):5690–7.

Koran LM, Hanna GL, Hollander E, Nestadt G, Simpson HB. Practice guideline for the treatment of patients with obsessive-compulsive disorder. Am J Psychiatry. 2007 Jul. 164(7 Suppl):5-53.

Kurlan R (2004) Disabling repetitive behaviors in Parkinson's disease. Mov Disord 19: 433-469

Kuwano M, Nakao T, Yonemoto K, Yamada S, Murayama K, Okada K, et al. (March 2020). “Clinical characteristics of hoarding disorder in Japanese patients”. Heliyon. 6 (3): e03527. Do-i:10.1016/j.heliyon.2020.e03527.

LaPlante DA, Nelson SE, LaBrie RA, Shaffer HJ. Disordered gambling, type of gambling and gambling involvement in the British Gambling Prevalence Survey 2007. Eur J Public Health. 2011; 21:532-537.

Leeman RF, Billingsley BE, Potenza MN. Impulse control disorders in Parkinson’s Disease: background and update on prevention and management. Neurodegener Dis Manag. 2012; 2:389-400.

Leppink EW, Redden SA. Cognitive flexibility correlates with gambling severity in young adults, J Psychiatr Res. 2016; 81:9-15.

Lin PY. Meta-analysis of the association of serotonin transporter gene polymorphism with obsessive-compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2007 Apr 13. 31(3):683-9.

Lobo DS, Aleksandrova L, Knight J, et al. Addiction-related genes in gambling disorders: new insights from parallel human and pre-clinical models. Mol Psychiatry. 2015; 20:1002-1010.

Lochner C et al. (2005) Cluster analysis of obsessive-compulsive spectrum disorder in patients with obsessive-compulsive disorder: clinical and genetic correlates. Comp Psychiatry 46: 14-19

Mallet L, Polosan M, Jaafari N, Baup N, Welter ML, Fontaine D, et al. Subthalamic nucleus stimulation in severe obsessive-compulsive disorder. N Engl J Med. 2008 Nov 13. 359(20):2121- 34.

Marcks BA, Weisberg RB, Dyck I, Keller MB. Longitudinal course of obsessive-compulsive disorder in patients with anxiety disorders: a 15-year prospective follow-up study. Compr Psychiatry. 2011;52(6):670–7.

Marinova Z, Chuang DM, Fineberg N. Glutamate-modulating drugs as a potential therapeutic strategy in obsessive-compulsive disorder. Curr Neuropharm. 2017;15(7):977–95.

Morasco BJ et al. (2006) Severity of gambling is associated with physical and emotional health in urban primary care patients. Gen Hosp Psychiatry 28: 94-100

Nirenberg MJ and Waters C (2005) Compulsive eating and weight gain related to dopamine agonist use. Mov Disord 21: 524-529

Norberg MM, Crone C, Kwok C, Grisham JR (March 2018). “Anxious attachment and excessive acquisition: The mediating roles of anthropomorphism and distress intolerance”. Journal of Behavioral Addictions. 7 (1): 171–180. Doi:10.1556/2006.7. 2018.08.

Norberg MM, Kwok C, Crone C, David J, Kakar V, Grisham JR (2020). “Greater interpersonal problems differentiate those who excessively acquire and save from those who only excessively acquire possessions”. Journal of Obsessive-Compulsive and Related Disorders. 27: 100571. Doi:10.1016/j.jocrd.2020.100571.

Nordsletten, A.E., Fernández de la Cruz, L., Pertusa, A., Reichenberg, A., Hatch, S.L., Mataix-Cols, D., 2013. The Structured Interview for Hoarding Disorder (SIHD): Development, usage and further validation. Journal of Obsessive Compulsive and Related Disorders 2(3), 346- 350.

Odlaug BL, Grant JE. Impulse-control disorders in a college sample: results from the self-administered Minnesota Impulse Disorders Interview (MIDI). Prim Care Companion J Clin. Psychiatry. 2010; 12(2)

Pepper J, Hariz M, Zrinzo L. Deep brain stimulation versus anterior capsulotomy for obsessive-compulsive disorder: a review of the literature. J Neurosurg. 2015 May. 122 (5):1028-37.

Pertusa A, Frost RO, Fullana MA, Samuels J, Steketee G, Tolin D, et al. (June 2010). “Refining the diagnostic boundaries of compulsive hoarding: a critical review”. Clinical Psychology Review. 30 (4): 371–386. Doi:10.1016/j.cpr.2010.01.007.

Petrovic P, Pleger B, Seymour B, et al. Blocking central opiate function modulates hedonic impact and anterior cingulate response to rewards and losses. J Neurosci. 2008; 28:10509-10516.

Petry NM (2001) Substance abuse, pathological gambling, and impulsiveness. Drug Alcohol Depend 63: 29-38

Petry NM (2003) Gambling participation and problems among Southeast Asian refugees. Psychiatr Serv 54: 1142-1148

Petry NM et al. (2005) Co-morbidity of DSM-IV pathological gambling and other psychiatric disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry 66: 564-574

Petry NM, Ammerman Y, Bohl J, et al. Cognitive-behavioral therapy for pathological gamblers. J Consult Clin Psychol. 2006; 74:555-567.

Petry NM, Litt MD, Kadden R, et al. Do coping skills mediate the relationship between cognitive-behavioral therapy and reductions in gambling in pathological gamblers? Addiction. 2007; 102:1280-1291.

Pezzella FR et al. (2005) Prevalence and clinical features of hedonic homeostatic dysregulation in Parkinson's disease. Mov Disord 20: 77-81

Pietrzak RH et al. (2007) Gambling level and psychiatric and medical disorders in older adults: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Am J Geriatr Psychiatry 15: 301-313

Pontone G et al. (2006) Clinical features associated with impulse control disorders in Parkinson disease. Neurology 67: 1258-1261

Postlethwaite, A., Kellett, S., Mataix-Cols, D., 2019. Prevalence of Hoarding Disorder: A systematic review and meta-analysis. J Affect Disord 256, 309-316.

Potenza MN (2006) Should addictive disorders include non-substance-related conditions? Addiction 101: 142-151

Potenza MN (2007) Impulse control disorders and co-occurring disorders: dual diagnosis considerations. J Dual Diagn 3: 47-57

Potenza MN (2007) Impulsivity and compulsivity in pathological gambling and obsessive-compulsive disorder. Rev Bras Psiquiatr 29: 105-106

Potenza MN et al. (2005) Shared genetic contributions to pathological gambling and major depression in men. Arch Gen Psychiatry 62: 1015-1021

Potenza MN et al. (2006) Characteristics of older adult problem gamblers calling a gambling helpline. J Gambl Stud 22: 241-254

Potenza MN, I, Balodis M, Franco CA, et al. Neurobiological considerations in understanding behavioral treatments for pathological gambling. Psychol Addict Behav. 2013; 27:380-392.

Potenza MN, Koran LM, Pallanti S. The relationship between impulse-control disorders and obsessive-compulsive disorder: a current understanding and future research directions. Psychiatr Res. 2009; 170:22-31.

Potenza MN, Sofuoglu M, Carroll KM, et al. Neuroscience of behavioral and pharmacological treatments for addictions. Neuron. 2011; 69: 695-712.

Potenza MN. Non-substance addictive behaviors in the context of DSM-5. Addict Behav. 2014; 39:1-2.

Rahman AS, Xu J, Potenza MN. Hippocampal and amygdalar volumetric differences in pathological gambling: a preliminary study of the associations with the behavioral inhibition system. Neuropsychopharmacology. 2014; 39:738-745.

Reuter J et al. (2005) Pathological gambling is linked to reduced activation of the mesolimbic reward system. Nat Neurosci 8: 147-148

Saxena S (May 2011). “Pharmacotherapy of compulsive hoarding”. Journal of Clinical Psychology. 67 (5): 477–484. Doi:10.1002/jclp.20792.

Sayyah M, Sayyah M, Boostani H, Ghaffari SM, Hoseini A. Effects of aripiprazole augmentation in treatment-resistant obsessive-compulsive disorder (a double blind clinical trial). Depress Anxiety. 2012;29(10):850–4

Schneier FR, Martinez D, Abi-Dargham A, et al. (2008) Striatal dopamine D(2) receptor availability in OCD with and without comorbid social anxiety disorder: preliminary findings. Depress Anxiety 25:1–7.

Schreiber LN, Grant JE, Odlaug BL. Emotion regulation and impulsivity in young adults. Journal of Psychiatric Research. 2012; 46(5): 651-658.

Serrano-Dueñas M (2002) Chronic dopamimetic drug addiction and pathologic gambling in patients with Parkinson's disease-presentation of four cases. German J Psychiatry 5: 62-66

Simpson HB, Foa EB, Liebowitz MR, et al. Cognitive-Behavioral Therapy vs Risperidone for Augmenting Serotonin Reuptake Inhibitors in Obsessive-Compulsive Disorder: A Randomized Clinical Trial. JAMA Psychiatry. Sep 11 2013.

Simpson HB, Wetterneck CT, Cahill SP, Steinglass JE, Franklin ME, Leonard RC, et al. Treatment of obsessive-compulsive disorder complicated by comorbid eating disorders. Cogn Behav Ther. 2013 Mar. 42(1):64-76.

Slutske WS, Ellingson JM, Richmond-Rakerd LS, et al. Shared genetic vulnerability for disordered gambling and alcohol use disorder in men and women: evidence from a national community-based Australian Twin Study. Twin Res Hum Genet. 2013; 16:525-534.

Slutske WS, Moffitt TE, Poulton R, Caspi A. Under-controlled temperament at age 3 predicts disordered gambling at age 32: a longitudinal study of a complete birth cohort. Psychol Sci. 2012; 23:510-516.

Slutske WS, Zhu G, Meier MH, Martin NG. Genetic and environmental influences on disordered gambling in men and women. Arch Gen Psychiatry. 2010; 67:624-630.

Smeding HMM et al. (2007) Pathological gambling after bilateral subthalamic nucleus stimulation in Parkinson's disease. J Neurol Neurosurg 78: 517-519

St Onge JR, Floresco SB. Dopaminergic modulation of risk-based decision making. Neuropsychopharmacology. 2009; 34:681-697.

Stetka B, Correll, C. A Guide to DSM-5: Hoarding, Skin-Picking, and Rethinking OCD. Available. Medscape Medical News. Available at http://www.medscape.com/viewarticle/803884_7. Accessed: July 1, 2013.

Szarfman A et al. (2006) Association between pathological gambling and parkinsonian therapy as detected in the Food and Drug Administration Adverse Event database. Arch Neurol 63: 299-300

Tamminga CA and Nestler EJ (2006) Pathological gambling: focusing on the addiction, not the activity. Am J Psychiatry 163: 180-181

Tolin DF, Frost RO, Steketee G, Muroff J (March 2015). “Cognitive Behavioural therapy for hoarding disorder: a meta-analysis”. Depression and Anxiety. 32 (3): 158–166. Doi:10.1002/ da.22327.

Tolin DF, Meunier SA, Frost RO, Steketee G (September 2010). “Course of compulsive hoarding and its relationship to life events”. Depression and Anxiety. 27 (9): 829–38. Doi:10.1002/ da.20684.

Tolin, D.F., Frost, R.O., Steketee, G., 2010. A brief interview for assessing compulsive hoarding: The Hoarding Rating Scale-Interview. Psychiatry Res 178(1), 147-152.

Volberg RA, Gupta R, Griffiths MD, Olason DT, et al. An international perspective on youth gambling prevalence studies. Int J Adolesc Med Health. 2010; 22:3-38.

Voon V et al. (2006) Prospective prevalence of pathological gambling and medication association in Parkinson's disease. Neurology 66: 1750-1752

Voon V et al. (2007) Medication-related impulse control and repetitive behaviors in Parkinson's disease. Curr Opin Neurol 20: 484-492

Voon V, Sohr M, Lang AE, et al. Impulse control disorders in Parkinson disease: a multicenter case-control study. Ann Neurol. 2011; 69:986-996.

Weintraub D and Potenza MN (2006) Impulse control disorders in Parkinson's disease. Curr Neurol Neurosci Rep 6: 302-306

Wilber MK and Potenza MN (2006) Adolescent gambling: research and clinical implications. Psychiatry 2006 3: 40-48

Wilson D, da Silva Lobo DS, Tavares H, et al. Family-based association analysis of serotonin genes in pathological gambling disorder: evidence of vulnerability risk in the 5HT-2A receptor gene. J Mol Neurosci. 2013; 49:550-553.

Yazıcı K, Yazıcı A. Dürtüselliğin nöroanatomik ve nörokimyasal temelleri. Psikiyatride Güncel Yaklaşımlar 2010; 2(2):254-80.

Yin HH and Knowlton BJ (2006) The role of basal ganglia in habit formation. Nat Neurosci 7: 464-476

Zack M and Poulos CX (2007) A D2 antagonist enhances the rewarding and priming effects of a gambling episode in pathological gamblers. Neuropsychopharmacology 32: 1678-1686